USANA Health Sciences “buy,” target price reduced – newratings.com
In a research note published this morning, the analyst mentions that the company has posted its results for the previous quarter in-line with the expectations. USANA Health Sciences has reduced its EPS guidance for FY08 from $2.94-$3.02 to $2.86-$2.94, possibly due to the company’s US sales growth, weak consumer economy in the US and concerns regarding associate growth in the US, the analyst adds. The EPS estimate for 2008 has been reduced from $3.05 to $2.90.
Powered by ScribeFire.
No comments yet.